Medifast (MED) Current Leases (2013 - 2026)

Medifast has reported Current Leases for 12 years, with the latest figure at $3.9 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases fell 36.32% year-over-year to $3.9 million; the trailing twelve-month figure through Mar 2026 stood at $3.9 million (down 36.32% YoY), and the FY2025 full-year result was $4.6 million, down 25.54% from the prior year.
• Current Leases for Q1 2026 stood at $3.9 million, down from $4.6 million in the prior quarter.
• The five-year high for Current Leases was $6.7 million in Q1 2022, with the low at $3.9 million in Q1 2026.
• Historically, Current Leases has averaged $5.7 million across 5 years, with a median of $5.9 million in 2025.
• Annual changes were most pronounced in 2022 — Current Leases soared 82.5% — and 2026, when it tumbled 36.32%.
• Medifast's Current Leases stood at $5.8 million in 2022, then rose by 1.89% to $5.9 million in 2023, then gained by 5.05% to $6.2 million in 2024, then declined by 25.54% to $4.6 million in 2025, then decreased by 14.84% to $3.9 million in 2026.
• The last three Current Leases figures came in at $3.9 million (Q1 2026), $4.6 million (Q4 2025), and $5.5 million (Q3 2025), per Business Quant data.